Antioxidant Activity of Plicatin B on Cultured Human Microvascular Endothelial Cells Exposed to H₂O₂

REFERENCES

• Achmad T. H., Rao G. S. Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers. Biochem. Biophys. Res. Commun. 1992; 189: 994–1000
   PubMed Web of Science ®Google Scholar
• Ades E., Kandal F., Sverlick R., Gorge W., Summers S., Bosse D. C., Lawley T. J. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. Invest. Dermatol. 1992; 99: 683–690
   PubMed Web of Science ®Google Scholar
• Alexander R. W. Theodore Cooper memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995; 25: 155–161
   PubMed Web of Science ®Google Scholar
• Baldi S., Maurich T., Lubrano V., Turchi G. Antioxidant properties of the chalcone plicatin B. Proceedings of (Eighth International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis). October, 4–8, G. Bronzetti, L. R. Ferguson, S. DeFlora. PisaItaly 2003; 14
   Google Scholar
• Banting J. D., Friberg P., Adams M. A. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J. Hypertens 1996; 14: 975–981
   PubMed Web of Science ®Google Scholar
• Bath P., Hassal D., Gladwin A., Palmer R., Martin J. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler. Thromb. Vasc. Biol. 1991; 11: 254–260
   PubMed Web of Science ®Google Scholar
• Belguendouz L., Fremont L., Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem. Pharmacol. 1997; 53: 1347–1355
   PubMed Web of Science ®Google Scholar
• Bevilacqua M. P. Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol. 1993; 11: 767–804
   PubMed Web of Science ®Google Scholar
• Bohm F., Johansson B. L., Hedin U., Alving K., Pernow J. Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1. Atherosclerosis 2002; 160: 215–222
   PubMed Web of Science ®Google Scholar
• Bors W., Heller W., Michel C., Saran M. Flavonoids as antioxidants: determination of radical scavenging efficiencies. Methods Enzymol. 1990; 186: 343–355
   PubMed Web of Science ®Google Scholar
• Bradley J. R., Johnson D. R., Pober J. S. Endothelial activation by hydrogen peroxide. Selective increases of intercellular adhesion molecule-1 and major histocompatibility complex class I. Am. J. Pathol. 1993; 142: 1598–1607
   PubMed Web of Science ®Google Scholar
• Calliste C. A., Le Bail J. C., Trouillas P., Pouget C., Habrioux G., Chulia A.-J., Duroux J. l. Chalcones: structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer. Res. 2001; 21: 3949–3956
   PubMed Web of Science ®Google Scholar
• Choi S. H., Lee Y., Kim S. U., Jin B. K. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J. Neurosci. 2005; 25: 4082–4090
   PubMed Web of Science ®Google Scholar
• De Vincenzo R., Ferlini C., Distefano M., Saggini C., Riva A., Bombardelli E., Morazzoni P., et al. In vitro evaluation of newly developed chalcone analogues in human cancer cells. Cancer Chem. Pharm. 2000; 46: 305–312
   PubMed Web of Science ®Google Scholar
• Ducki S., Forrest R., Hadfield J. A., Kendall A., Nicholas J. L., McGown A. T., Rennison D. Potent antimitotic and cell growth inhibitory properties of substituted chalcones. Bioorg. Med. Chem. Lett. 1998; 8: 1051–1056
   PubMed Web of Science ®Google Scholar
• Farombi E. O., Nwwaokeafor I. A. Anti-oxidant mechanisms of kaloviron: Studies on serum lipoprotein oxidation, metal chelation and oxidative membrane damage in rats. Clin. Exp. Pharm. Physiol. 2005; 32: 667–674
   PubMed Web of Science ®Google Scholar
• Fenech M. Optimisation of micronucleus assays for biological dosimetry. New Horizons in Biological Dosimetry, B. L. Gledhill, F. Mauro. Wiley-Liss, New York 1991; 373–386
   Google Scholar
• Fukuroda T., Noguchi K., Tsuchida S., Nishikibe M., Ikemoto F., Okada K., Yano M. Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem. Biophys. Res. Commun. 1990; 171: 390–395
   Google Scholar
• Garg U., Hassid A. Nitric oxide-generation vasodilatators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 1989; 83: 1774–1777
   PubMed Web of Science ®Google Scholar
• Green L., Wagner D., Glogowski J., Skipper P., Wishnok J., Tannenbaum S. Analysis of nitrite, nitrate and [15N]nitrate in biological fluids. Anal. Biochem. 1982; 126: 131–138
   PubMed Web of Science ®Google Scholar
• Harrison V. J., Barnes K., Turner A. J., Wood E., Corder R., Vane J. R. Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 1995; 92: 6344–6348
   PubMed Web of Science ®Google Scholar
• Havsteen B. H. The biochemistry and medical significance of the flavonoids. Pharmcol. Ther. 2002; 96: 67–202
   PubMed Web of Science ®Google Scholar
• Herencia F., Ferràndiz M. L., Ubeda A., Dominguez J. N., Charris J. E., Lobo G. M., Alcarez M. J. Synthesis and anti-inflammatory activity of chalcone derivatives. Bioorg. Med. Chem. Lett. 1998; 8: 1169–1174
   PubMed Web of Science ®Google Scholar
• Hinson J. P., Kapas S., Cameron L. A. Differential effects of endogenous and exogenous nitric oxide on the release of endothelin-1 from the intact perfused rat adrenal gland in situ. FEBS Lett. 1996; 379: 7–10
   PubMed Web of Science ®Google Scholar
• Ikeda M., Schroeder K. K., Mosher L. B., Woods C. W., Akeson A. L. Suppressive effect of antioxidants on intercellular adhesion molecule-1 (ICAM-1) expression in human epidermal keratinocytes. J. Invest. Dermatol. 1994; 103: 791–796
   PubMed Web of Science ®Google Scholar
• Ikeda H., Takajo Y., Murohara T., Ichiki K., Adachi H., Haramaki N. Platelet-derived nitric oxide and coronary risk factors. Hypertension 2000; 35: 904–907
   PubMed Web of Science ®Google Scholar
• Ikegawa R., Matsumura Y., Tsukahara Y., Takaoka M., Morimoto S. Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzymes. Biochem. Biophys. Res. Commun. 1990; 171: 669–675
   PubMed Web of Science ®Google Scholar
• Ikura T., Sawamura T., Shiraka T., Hosokawa H., Kido T., Hoshikawa H., Shimada K., Tanzawa K., Kobayashi S., Miwa S., Masaki T. cDNA cloning and expression of bovine endothelin converting enzyme. Biochem. Biophys. Res. Commun. 1994; 203: 1417–1422
   PubMed Web of Science ®Google Scholar
• Iwata S., Nishino I. S., Nagata N., Satomi Y., Nishino H., Shibata S. Antitumorigenic activities of chalcones. I. Inhibitory effects of chalcone derivatives on 32Pi-incorporation into phospholipids of HeLa cells promoted by 12-O-tetradecanoyl-phorbol 13-acetate (TPA). Biol. Pharm. Bull. 1995; 18: 1710–1713
   PubMed Web of Science ®Google Scholar
• Kahler J., Mendel S., Weckmuller J., Orzechowski H.-D., Mittmann C., Koster R., Martin P., Meinertz T., Munzel T. Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J. Mol. Cell Cardiol. 2000; 32: 1429–1437
   PubMed Web of Science ®Google Scholar
• Keller P. M., Lee C-P, Fenwick A. E., Atkinson S. T., Elliot J. D., DeWolf W. E. Endothelin converting enzyme: substrate specificity and inhibition by novel analogs of phosphoramidon. Biochem. Biophys. Res. Commun. 1996; 223: 372–378
   PubMed Web of Science ®Google Scholar
• Kenneth A. R., Rahman A., Lakshminarayanan V., Janakidevi K., Malik A. B. H2O2 and tumor necrosis factor- activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distint cis-regulatory elements within the ICAM-1 promoter. J. Biol. Chem. 1995; 270: 18966–18974
   PubMed Web of Science ®Google Scholar
• Lawrence N. J., McGown A. T., Ducki S., Hadfield J. A. The interaction of chalcones with tubulin. Anti-Cancer Drug Design 2000; 15: 135–141
   PubMedGoogle Scholar
• Le Bail J. C., Varnat F., Nicolas J. C., Habrioux G. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett. 1998; 130: 209–216
   PubMed Web of Science ®Google Scholar
• Lerman A., Holmes D. R., Jr., Bell M. R., Garratt K. N., Nishimura R. A., Burnett J. C., Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in human. Circulation 1995; 92: 2426–2431
   PubMed Web of Science ®Google Scholar
• Liu T., Stern A., Roberts L. J., Morrow J. D. The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid. J. Biomed. Sci. 1999; 58: 226–235
   Google Scholar
• Lo S. K., Janakidevi K., Lai L., Malik A. B. Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am. J. Physiol. 1993; 264: 1406–1412
   Google Scholar
• Lubrano V., Vassalle C., Blandizzi C., Del Tacca M., Palombo C., L'Abbate A., Baldi S., Natali A. The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides. Eur. J. Clin. Invest. 2003; 33: 117–125
   PubMed Web of Science ®Google Scholar
• Maurich T., Pistelli L., Turchi G. Anti-clastogenic activity of two structurally related pterocarpans purified from Bituminaria bituminosa in cultured human lymphocytes. Mutat. Res. 2004; 561: 75–81
   PubMed Web of Science ®Google Scholar
• McMahon E. G., Palomo M. A., Moore W. M., McDonald J. F., Stern M. K. Phosphoramidon bloks the pressor activity of porcine big endothelin-1(1–39) in vivo and coversion of big endothelin-1(1–39) to endothelin-1-(1–21) in vitro. Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 703–707
   PubMed Web of Science ®Google Scholar
• Menon S. R., Patel V. K., Mitscher L. A., Shih P., Pillai S. P., Shankel D. M. Structure-antimutagenic activity relationship study of plicatin B. J. Nat. Prod. 1999; 62: 102–106
   PubMed Web of Science ®Google Scholar
• Melidou M., Riganakos K., Galaris D. Protection against nuclear DNA damage offered by flavonoids in cells exposed to hydrogen peroxide: The role of iron chelation. Free. Radic. Biol. Med. 2005; 39: 1591–1600
   PubMed Web of Science ®Google Scholar
• Mitscher L. A., Telikepalli H., McGhee E., Shankel D. M. Natural antimutagenic agents. Mutat. Res. 1996; 350: 143–152
   PubMed Web of Science ®Google Scholar
• Miyauchi T., Masaki T. Pathophysiology of endothelin in the cardiovascular system. Ann. Rev. Physiol. 1999; 61: 391–415
   PubMed Web of Science ®Google Scholar
• Mori T., Cowley A. W., Jr, Ito S. Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla. J. Pharmacol Sci. 2006; 100: 2–8
   PubMed Web of Science ®Google Scholar
• Morris C. J., Earl J. R., Trenam C. W., Blake D. R. Reactive oxygen species and iron a dangerous partnership in inflammation. Int. J. Biochem. Cell Biol. 1995; 27: 109–122
   PubMed Web of Science ®Google Scholar
• Patronò C., FitzGerald G. A. Isoprostanes: potential markers of oxidant stress in atherotrombotic disease. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2309–2315
   PubMed Web of Science ®Google Scholar
• Roebuck K. A., Brenner D. A., Kagnoff M. F. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1. J. Clin. Invest. 1993; 92: 1336–1348
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis-An update. N. Engl. J. Med. 1986; 314: 488–500
   PubMed Web of Science ®Google Scholar
• Schmidt M., Kroger B., Jacob E., Seulberger H., Subkowski T., Otter R., Meyer T., Schmalzing G., Hillen H. Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett. 1994; 356: 238–243
   PubMed Web of Science ®Google Scholar
• Sellak H., Franzini E., Hakim J., Pasquier C. Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood 1994; 83: 2669–2677
   PubMed Web of Science ®Google Scholar
• Sessa W., Pritchard K., Seyedi N., Wang J., Hintze T. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 1994; 74: 349–353
   PubMed Web of Science ®Google Scholar
• Springer T. A. Adhesion receptors of the immune system. Nature 1990; 344: 425–434
   Google Scholar
• Subauste M. C, Choi D-C., Proud D. Transient exposure of human bronchial epithelial cells to cytokines leads to persistent increased expression of ICAM-1. Inflammation 2001; 25: 373–379
   PubMed Web of Science ®Google Scholar
• Van Acker S. A., van den Berg D. J., Tromp M. N., Griffioen D. H., van Bennekom W. P., van der Vijgh W. J., Bast A. Structural aspects of antioxidant activity of flavonoids. Free Rad. Biol. Med. 1996; 20: 275–283
   Google Scholar
• Zhang C., Hein T. W., Wang W., Ren Y., Shipley R. D., Kuo L. Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles. J. Mol. Cell. Cardiol. 2006; 40: 247–257
   PubMed Web of Science ®Google Scholar